Bibliographic information

GuidelineSelected practice recommendations for contraceptive use, 4th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

New

Nonsteroidal anti-inflammatory drugs (NSAIDs) may be offered routinely for intrauterine device (IUD) placement. IUDs should not be withheld if NSAIDs are not available.

Recommended in favor

Conditional

Notes and Remarks

Barriers to IUD use include client concerns about anticipated pain with placement and provider concerns about ease of placement, especially among nulliparous clients. Therefore, before an IUD is placed, all clients should be counselled on the possibility of pain during placement, the risks and benefits of an IUD, and alternatives to it. They should also be told about the different options for pain management. A person-centred plan for IUD placement and pain management should be made and it should be based on client preferences. There are many different types of NSAIDs, and oral formulations that can be self-administered for pain relief are widely available. NSAIDs can be offered routinely before IUD placement. Evidence on NSAIDs generally suggested a small to moderate decrease in client pain, and inconsistent results with client satisfaction with the procedure. ‒Evidence suggests that NSAIDs do not increase side-effects (e.g. nausea, vomiting, dizziness or drowsiness). ‒The GDG noted that generic forms of oral NSAIDs are widely available and a single dose is generally very well tolerated.